Related Experiment Video
Updated: Mar 22, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
The left atrial appendage: from embryology to prevention of thromboembolism
Giuseppe Patti1, Vittorio Pengo2, Rossella Marcucci3
1Institute of Cardiology, Campus Bio-Medico University, Rome, Italy.
Insights
The left atrial appendage (LAA) is a primary source of blood clots in non-valvular atrial fibrillation (AF). Understanding LAA anatomy, thrombosis, and treatment is crucial for managing AF patients and preventing thromboembolism.
Area of Science:
- Cardiology
- Medical Imaging
- Thrombosis Research
Background:
- The left atrial appendage (LAA) is a significant source of thromboembolism in patients with non-valvular atrial fibrillation (AF).
- Effective management of AF necessitates a thorough understanding of LAA structure, function, and thrombosis.
- Current therapeutic strategies increasingly target the LAA for intervention.
Purpose of the Study:
- To provide foundational knowledge on LAA anatomy and function.
- To review current imaging modalities for identifying LAA anatomical variations.
- To elucidate the pathogenesis of LAA thrombosis and examine treatment options in AF patients.
Main Methods:
- Review of anatomical and functional aspects of the LAA.
- Analysis of current imaging techniques for LAA morphology.
- Examination of pathogenetic mechanisms of LAA thrombosis.
- Evidence review of treatment strategies, including anticoagulation and interventional therapies.
Main Results:
- The LAA's critical role in AF-related thromboembolism is confirmed.
- Various imaging tools aid in characterizing LAA anatomy and identifying variations.
- Understanding LAA thrombosis mechanisms informs treatment selection.
- Non-vitamin K antagonist oral anticoagulants and interventional approaches are key treatment strategies.
Conclusions:
- Comprehensive knowledge of LAA anatomy, thrombosis, and imaging is essential for optimal AF patient management.
- Targeting the LAA with device therapies is a viable strategy for thromboembolism prevention.
- A multi-faceted approach combining medical and interventional treatments is key for managing LAA-related risks in AF.
Abstract:
The left atrial appendage (LAA) is the main source of thromboembolism in patients with non-valvular atrial fibrillation (AF). As such, the LAA can be the target of specific occluding device therapies. Optimal management of patients with AF includes a comprehensive knowledge of the many aspects related to LAA structure and thrombosis. Here we provide baseline notions on the anatomy and function of the LAA, and then focus on current imaging tools for the identification of anatomical varieties. We also describe pathogenetic mechanisms of LAA thrombosis in AF patients, and examine the available evidence on treatment strategies for LAA thrombosis, including the use of non-vitamin K antagonist oral anticoagulants and interventional approaches.
Related Concept Videos
Development of the Heart
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis I: Introduction
Chambers of the Heart
Deoxygenated blood from the body is received in the right...

